A Study to Compare the Effect of Yashtimadhu-Antamula and Bharangi Mool Arka Nebulization in Managing Childhood Bronchial Asthma

A Randomized Open Label Comparative Clinical Study to evaluate the efficacy of Yashtimadhu-Antamula and Bharangi Mool Arka Nebulization in the management of Tamaka Shwasa (Bronchial Asthma) in children - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/09/095348

Enrollment

Registered

2025-09-24

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Parents of children willing to participate in the research trial. 2. Children of age group 6-18 years. irrespective of Caste, Sex, Religion and socioeconomic status. 3. The patient having classical sign and symptoms of Tamaka Shwasa. (Bronchial Asthma).

Exclusion criteria

Exclusion criteria: 1. Any acute or severe illness during treatment. 2. Parents not willing to continue the treatment. 3. Any kind of anaphylactic reaction.

Design outcomes

Primary

Measure	Time frame
Improvement in the classical signs and symptoms of Tamaka Shwasa such as Shwasa Kashtata, Kasa, Ghurghur Shabda, Peenasa, Asino labhte Saukhayam as well as in PEF and spirometry gradingTimepoint: 7 days	—

Secondary

Measure	Time frame
Clinical safety and tolerability of Yashtimadhu-Antamula Nebulization in the management of Tamaka Shwasa (Bronchial Asthma) will be assessed.Timepoint: 7th and 14th Day	—

Countries

India

Contacts

Public ContactDr Prachi Thind

Institute for Ayurved Studies and Research

dramitkataria@rediffmail.com9034001230

Outcome results